David Tsai, MD
Surgery of the Hand · Pennington, NJNPI 1629457296
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (52.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Arthrex at 55.5% of the total. Reporting peaked in 2022 at $3,315 and has fallen 71.8% since, to $934 in 2025.
Across 36 payments — averaging $127.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$3K
- Skeletal Dynamics Inc$781
- Seapearl East, Inc$357
- Integra Lifesciences Corporation$258
- Trimed, Inc.$193
- Acera Surgical, Inc.$180
- plus $271 from 9 others
What the payments were for
- Travel & lodging$1,17626%
- Food & beverage$1,01222%
- Education$2,40052%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 9 | $2,548 |
| Skeletal Dynamics Inc | 3 | $781 |
| Seapearl East, Inc | 1 | $357 |
| Integra Lifesciences Corporation | 6 | $258 |
| Trimed, Inc. | 1 | $193 |
| Acera Surgical, Inc. | 6 | $180 |
| Kerecis Limited | 2 | $52 |
| Dilon Technologies, Inc. | 1 | $50 |
| Dynasplint Systems Inc. | 1 | $44 |
| Bioventus LLC | 1 | $26 |
| Smith+Nephew | 1 | $25 |
| Polynovo North America LLC | 1 | $23 |
| Bonalive Inc | 1 | $20 |
| Endo USA, Inc. | 1 | $16 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Geminus$753
- Align$753
- IJS$753
- Implate$753
- AMNIOEXCEL$123
- TCC-EZ$123
- OMNIGRAFT$123
- INTEGRA DERMAL REGENERATION TEMPLATE$123
- PRIMATRIX$123
How this compares
Too few surgery of the hand providers in New Jerseyto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 28 | $213 |
| Cephalexin | 21 | $138 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Pennington
- Ajul ShahPennington$104K
- Renata WeberRutherford$9K
- Eric StraussVoorhees$9K
- Gary BreslowParamus$7K
- Stephen DudickGalloway$6K
- Jeffry JacobsOradell$4K
- Oren MichaeliEnglewood$4K
- Steven UgrasParamus$2K
- Caroline McLaughlinCamden$2K
- Abram KirschenbaumDenville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.